Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.089% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. CCC(=O)NC(c1cc(Cl)c2cccnc2c1O)C(C)C
b. O=c1c2ccccc2nc(-c2ccc([N+](=O)[O-])cc2)n1O
Answer: a. CCC(=O)NC(c1cc(Cl)c2cccnc2c1O)C(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)NC(c1cc(Cl)c2cccnc2c1O)C(C)C
CCC(=O)NC(c1cc(Cl)c2cccnc2c1O)C(C)C
N-[1-(5-chloro-8-hydroxyquinolin-7-yl)-2-methylpropyl]propanamide